Physician profile
David Zolfaghari
NPI 1104853316
$2,515.71
in general payments reported to CMS, 2019-2025
18 companies · $712 in 2025
The $712 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $256 · 2021: $210 · 2022: $159 · 2023: $475 · 2024: $271 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,457.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $718.29 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abiomed | $323.04 | 2019-2025 | |
| Pfizer INC. | $312.42 | 2019-2021 | |
| Atricure, INC. | $293.35 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Abbott Laboratories | $239.79 | 2024 | Mitraclip |
| Ethicon US, LLC | $150.90 | 2020-2021 | |
| Chiesi USA, INC. | $106.36 | 2019-2022 | |
| Medtronic, INC. | $74.09 | 2021-2023 | Gia, Ligasure |
| Artivion, INC. | $61.18 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $46.39 | 2019-2022 | |
| Amgen INC. | $44.27 | 2019-2020 | |
| Corcym INC | $33.08 | 2023 | Miami Instruments |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.60 | 2019-2023 | Lifevest |
| Inspire Medical Systems, INC. | $21.68 | 2025 | Inspire |
| Getinge USA Sales, LLC | $20.17 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $16.70 | 2023 | Injectafer |
| Davol INC. | $13.31 | 2019 | |
| Kls-Martin L.P. | $11.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Zolfaghari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.